Clinical Trial

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

Name: Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma — clinical trial record (NCT07492836)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HipoGBM

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to evaluate the feasibility, safety and effectiveness of radiotherapy with fewer days of treatment and a higher dose of radiation each day in patients under 70 years of age diagnosed with a brain tumor known as glioblastoma.

Trial Details

NCT Number	NCT07492836
Lead Sponsor	Hospital do Coracao
Conditions	Glioblastoma (GBM)
Enrollment	10 participants
Start Date	2026-04
Primary Completion	2026-10 (estimated)
Study Completion	2029-04 (estimated)
Updated on ClinicalTrials.gov	2026-03-25